SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — NGM Biopharmaceuticals Inc. (NGM) on Tuesday reported a loss of $36.4 million in its fourth quarter.
On a per-share basis, the South San Francisco, California-based company said it had a loss of 45 cents.
The results topped Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 52 cents per share.
The biotechnology company posted revenue of $18.2 million in the period, which also topped Street forecasts. Four analysts surveyed by Zacks expected $6.8 million.
For the year, the company reported that its loss widened to $162.7 million, or $2.03 per share. Revenue was reported as $55.3 million.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NGM at https://www.zacks.com/ap/NGM
Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.